Abbott Laboratories has launched its new balloon catheter in Europe to assist in the treatment of coronary artery disease.
The TREK Coronary Dilatation Catheter gives physicians the option to pre-dilate (open) a lesion before a stent is inserted. Pre-dilation has been shown to improve results when the stent is later expanded in a blood vessel.
Abbott says that this new design will help physicians treat challenging lesions and difficult-to-reach blockages.
The TREK system is available in 77 sizes and two designs, including the specialised MINI-TREK catheter, which is suitable for accessing smaller vessels.
The catheter was awarded the CE mark earlier this year. It is not available in the US.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData